RE:RE:Bash , pump investor . short.. otherThe interviews can't hurt, particularly with the likes of Lifton. However, I agree that only sales and proof of acceptance vis a vis Aristotle and AVPT will count from here on in. This is very much a "show me the money" stock due to over promising in the past and investors are simply not interested or impressed in hearing rosy but general forecasts. The next test will be Q2 when we see what cancer revenue actually looks like. In between we are all obviously hoping for a big signing on the cancer front as covid revenue clearly will not move the needle here. I have to think as well that eyes are on Aristotle, particularly if we believe it to be what it is.
Mermer2328 wrote:
szls SP will only move lower on silence. James doing his piddly interviews means little to investors that have watched him eat his words over the last few years Show us the contracts, Arostotke tests performed among many other happenings.. that's what will move the SP.... nothing else By now they should know that